Valuation: CellaVision AB

Market Cap 411.2Cr 41Cr 36Cr 34Cr 31Cr 58Cr 3.94TCr 59Cr 159.18Cr 2.01TCr 153.64Cr 150.31Cr 6.44TCr P/E 2026 *
29.2x
P/E 2027 * 23.2x
Enterprise Value 392.42Cr 39Cr 35Cr 32Cr 30Cr 56Cr 3.76TCr 56Cr 151.91Cr 1.91TCr 146.62Cr 143.44Cr 6.15TCr EV / Sales 2026 *
5.05x
EV / Sales 2027 * 4.44x
Free-Float
81.06%
Yield 2026 *
1.6%
Yield 2027 * 1.82%
1 day-0.87%
1 week+2.62%
Current month-0.46%
1 month+3.61%
3 months+26.58%
6 months+12.24%
Current year+9.67%
1 week 165.8
Extreme 165.8
180.6
1 month 157
Extreme 157
180.6
Current year 117.6
Extreme 117.6
180.6
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
459
10 years 75.25
Extreme 75.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Buy

Chief Executive Officer

8,077 0.0339%
02/09/26 Free 1,00,000 0.4193%
28/04/26 Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%+2.62%-0.12%+12.24% 41Cr
-3.34%-1.92%+34.53%+28.91% 25TCr
-4.42%-4.42%+6.81%-14.65% 16TCr
-1.33%+0.74%-10.28%+37.27% 14TCr
-0.96%-3.12%-55.72%-18.12% 6.33TCr
-1.31%-1.88%+9.54%+22.96% 4.98TCr
-3.27%+0.82%+29.86%+49.06% 4.86TCr
-0.95%+1.10%-18.27%-21.65% 4.8TCr
-1.23%+4.13%-5.36%+38.57% 4.62TCr
-3.15%+1.18%+41.93%+55.18% 4.32TCr
Average -2.03%+2.36%+3.29%+18.98% 8.48TCr
Weighted average by Cap. -2.47%+2.37%+8.59%+18.62%

Financials

2026 *2027 *
Net sales 78Cr 7.73Cr 6.87Cr 6.42Cr 5.85Cr 11Cr 744.59Cr 11Cr 30Cr 379.21Cr 29Cr 28Cr 1.22TCr 88Cr 8.72Cr 7.74Cr 7.24Cr 6.6Cr 12Cr 839.36Cr 13Cr 34Cr 427.47Cr 33Cr 32Cr 1.37TCr
Net income 14Cr 1.4Cr 1.24Cr 1.16Cr 1.06Cr 2Cr 134.8Cr 2.02Cr 5.45Cr 69Cr 5.26Cr 5.14Cr 220.5Cr 18Cr 1.79Cr 1.59Cr 1.48Cr 1.35Cr 2.54Cr 171.87Cr 2.58Cr 6.94Cr 88Cr 6.7Cr 6.56Cr 281.14Cr
Net Debt -19Cr -1.87Cr -1.66Cr -1.55Cr -1.41Cr -2.66Cr -179.98Cr -2.7Cr -7.27Cr -92Cr -7.02Cr -6.87Cr -294.4Cr -22Cr -2.23Cr -1.98Cr -1.85Cr -1.69Cr -3.18Cr -214.52Cr -3.22Cr -8.67Cr -109.25Cr -8.37Cr -8.18Cr -350.91Cr
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
01/26/01 SEK 172.40 -0.46% 18,172
30/26/30 SEK 173.20 -1.70% 19,098
29/26/29 SEK 176.20 +2.09% 26,833
28/26/28 SEK 172.60 -1.26% 39,342
25/26/25 SEK 174.80 +5.05% 29,471
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
172.40SEK
Average target price
180.00SEK
Spread / Average Target
+4.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock